About LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Genentech, Inc.
1
Clinical Trials at LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie
During the past decade, LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on
average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
A European Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced (LA) or Metastatic Breast Cancer (mBC) (SAMANTHA)
A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site
2018-07-10
2024-06-09
Active, not recruiting
790
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie"
#1 collaborator was "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator and "SOLTI Breast Cancer Research Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie
According to Clinical.Site data, the most researched conditions in "LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie" are
"Breast Cancer" (3 trials), "Breast Neoplasms" (1 trials), "Cancer of Unknown Primary Site" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Metastatic Prostate Cancer" (1 trials). Many other conditions were trialed in "LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie" in a lesser frequency.
Clinical Trials Intervention Types at LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie
Most popular intervention types in "LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Docetaxel" (2 trials), "Ipatasertib" (2 trials), "Paclitaxel" (2 trials) and "Pertuzumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie
The vast majority of trials in "LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie" are
6 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie
Currently, there are NaN active trials in "LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie".
undefined are not yet recruiting,
undefined are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".